Eye healthcare technology company Opternative secured $9 million in its latest round of funding led by Trust Ventures and Pritzker Group Venture Capital, with an additional investment from existing investor Jump Capital.
Opternative Inc., a Chicago-based healthcare technology company founded in 2012, offers an online vision test designed to allow patients to renew their prescription anywhere, anytime. According to the company, one million consumers have taken the test, and Opternative has issued hundreds of thousands of prescriptions with a 99.6% satisfaction rate. It also offers eye care providers, eyewear retailers, and other organizations customizable software solutions.
Opternative plans to use the funding to double its engineering, product, sales, and marketing teams, as well as to grow awareness and adoption of its online vision test with consumers, employers, and eye care providers.